Health Properties of Milk Fermented with Lactobacillus casei Strain Shirota (LcS)

Handbook of Fermented Functional Foods

Volumn , Issue , 2003, Pages 145-176

  Matsuzaki, Takeshi ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34447319227     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203009727-11     Document Type: Chapter

References (65)

1. Salminen, S. and von Wright, A., Eds., Lactic Acid Bacteria, Marcel Dekker, Inc., New York, 1993.
2. Stanier, R.Y., Doudoroff, M., and Adelberg, E.A., The Microbial World, Prentice-Hall, Inc., New York, 1957.
3. Tissier, H., Recherches sur La Flore Intestinale. Normale et Pathologique du Nour-risson, Georges Carre et C. Naud, Paris, 1900.
4. Moro, E., Uber die nach Gram farbbaren Bacillen des Sauglingsstuhles, Wien. Klin. Wochenschr., 13, 114–115, 1900.
5. Orla-Jensen, S., The Lactic Acid Bacteria, Host, Copenhagen, 1919, pp. 1–196.
6. Skerman, V.B.D., McGowan, V., and Sneath, P.H.A., Approved list of bacterial names, Int. J. Syst. Bacteriol., 30, 225–420, 1980.
7. Mitsuoka, T., Intestinal flora and animal models, in Proceedings of 2nd Symposium on Intestinal Flora: Intestinal Flora and Cancer, Part 2, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1995, pp. 3–27.
8. Lactobacillus casei strain Shirota — Intestinal Flora and Human Health, Yakult Central Institute for Microbiological Research, Tokyo, 1999.
9. Ryter, A. and Kellenberger, E., Etude au microscope electronique de plasmas conte-nant de l’acide desoxyribonucleique. I. Les nucleoides des bacteries en croissance active. Z. Naturforsch., 136, 597, 1958.
10. Amako, K., Fine structure of bacteria, in Electron Micrographs of Bacteria, Amako, K., Ed., Nanzando, Tokyo, 1983, pp. 16–89.
11. Nagaoka, M., Muto, M., Nomoto, K., Matsuzaki, T., Watanabe, T., and Yokokura, T., Structure of polysaccharide–peptidoglycan complex from the cell wall of Lactobacillus casei YIT9018, J. Biochem., 108, 568–571, 1990.
12. Smith, J., Protein surface layers of bacteria, in Bacterial Outer Membranes as Model Systems, Inoue, M., Ed., John Wiley and Sons Ltd., New York, 1986, pp. 343–376.
13. Kaneko, T., Morita, H., Abe, T., Uchida, K., Yamamoto, N., and Morishita, T., Nutrition and metabolism of lactic acid bacteria, in Science and Technology of Lactic Acid Bacteria, Japanese Scientific Societies Press, Tokyo, 1996, pp. 89–132.
14. Shimizu-Kadota, M., Properties of lactose plasmid pLY101 in Lactobacillus casei, Appl. Envron. Microbiol., 53, 2987–2991, 1991.
15. Yamachita, T., Takahashi, Y., Usami, A, Takahashi, H., and Aso, K., Flavor produced during lactic acid fermentation: part 1. Analysis of flavor factors, Annual Report of Yakult Central Institute for Microbiological Research, 2, 37–47, 1971.
16. Chang, I.S., Kim, B.H., and Shin, P.K., Use of sulfite and hydrogen peroxide to control bacterial contamination in ethanol fermentation, Appl. Environ. Microbiol., 63, 1–6, 1997.
17. Morishita, T., Fukuda, T., Shirota, T., and Yura, T., Genetic basis of nutritional requirements in Lactobacillus casei, J. Bacteriol., 120, 1078–1084, 1974.
18. De Man, J.C., Rogosa, M., and Sharpe, M.E., Medium for lactobacilli, J. Appl. Bacteriol., 23, 130–135, 1960.
19. Efthymiou, C. and Hansen, P.A., An antigenic analysis of Lactobacillus acidophilus, J. Infect. Dis., 110, 258–267, 1962.
20. Sansawa, H., in Lactobacillus casei strain Shirota — Intestinal Flora and Human Health, Yakult Central Institute for Microbiological Research, Tokyo, 1999, p. 94.
21. Kawami, K., Stability of Yakult beverage during storage, Reports on Yakult Beverage and Yakult Strain, No. 13, Yakult Co., Tokyo, 1980.
22. Shelef, L.A. and Firstenberg-Eden, R., Novel selective and nonselective optical detection of microorganisms, Lett. Appl. Microbiol., 25, 202–206, 1997.
23. Kolars, J.C., Yogurt: an autodigesting source of lactose, N. Engl. J. Med., 310, 1–3, 1984.
24. Mayer, E.A., The physiology of gastric storage and emptying, in Physiology of the Gastrointestinal Tract, 3rd ed., Johnson, L.R., Ed., Raven Press, New York, 1994, pp. 929–976.
25. Ohashi, Y. and Umesaki, Y., Kinetics of L. casei strain Shirota fermented milk in upper intestinal tract of the rat model, Dig. Absorp., 20, 119–123, 1997.
26. Ohashi, Y., Inoue, R., Tanaka, K., Matsuki, T., Umesaki, Y., and Uchida, K., Lactobacillus casei strain Shirota–fermented milk stimulates indigenous Lactobacilli in the pig intestine, J. Nutr. Sci. Vitaminol., 47, 172–176, 2001.
27. Yokokura, T., Kato, I., and Mutai, M., Antitumor effect of Lactobacillus casei (LC9018), in Intestinal Flora and Carcinogenesis, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1981, pp. 125–137.
28. Kato, I., Kobayashi, S., Yokokura, T., and Mutai., M., Antitumor activity of Lactobacillus casei in mice, Gann, 72, 517–523, 1981.
29. Matsuzaki, T., Yokokura, T., and Mutai, M., Antitumor effect of intrapleural administration of Lactobacillus casei in mice, Cancer Immunol. Immunother., 26, 209–214, 1988.
30. Takagi, A., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., and Yokokura, T., Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholan-threne-induced carcinogenesis in mice, Med. Microbiol. Immunol., 188, 111–116, 1999.
31. Matsuzaki, T., Tsukio, K., Yokokura, T., and Mutai, M., Effect of subcutaneous injection of a lactobacilli preparation, LC9018, and antitumor drugs on murine tumor, Biotherapy, 2, 440–445, 1988.
32. Matsuzaki, T., Yokokura, T., and Azuma, I., Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice, Cancer Immunol. Immunother., 24, 99–105, 1987.
33. Takagi, A., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., and Yokokura, T., Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism, Carcinogenesis, 22, 599–605, 2001.
34. Yasutake, N., Kato, I., Ohwaki, M., Yokokura, T., and Mutai, M., Host-mediated antitumor activity of Lactobacillus casei in mice, Gann, 75, 72–80, 1984.
35. Yasutake, N., Ohwaki, M., Mutai, M., Koide, Y., and Yoshida, T., Anti-tumor effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice, Cancer Immunol. Immunother., 20, 109–116, 1985.
36. Matsuzaki, T., Yokokura, T., and Azuma, I., Antitumor activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs, Cancer Immunol. Immunother., 20, 18–22, 1985.
37. Matsuzaki, T., Shimizu, Y., and Yokokura, T., Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei, Med. Microbiol. Immunol., 179, 161–168, 1990.
38. Miake, S., Nomoto, K., Yokokura, T., Yoshikai, Y., Mutai, M., and Nomoto, K., Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice, Infect. Immun., 48, 480–485, 1985.
39. Dalton, C.B., Austin, C.C., Sobel, J., Hayes, P.S., Bibb, W.F., Graves, L.M., Swam-inathan, B., Proctor, M.E., and Griffin, P.M., An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk, N. Engl. J. Med., 336, 100–105, 1997.
40. Nomoto, K., Miake, S., Hashimoto, S., Yokokura, T., Mutai, M., Yoshikai, Y., and Nomoto, K., Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei, J. Clin. Lab. Immunol., 17, 91–97, 1985.
41. Furushiro, M., Hashimoto, S., Hamura, M., and Yokokura, T., Mechanism of the antihypertensive effect of a polysaccharide–glycopeptide complex from Lactobacillus casei in spontaneously hypertensive rats (SHR), Biosci. Biotech. Biochem., 57, 978–981, 1993.
42. Furushiro, M., Sawada, S., Hirai, K., Motoike, M., Sansawa, H., Kobayashi, S., Watanuki, M., and Yokokura, T., Blood pressure-lowering effect of extract from Lactobacillus casei in spontaneously hypertensive rats (SHR), Agric. Biol. Chem., 54, 2193–2198, 1990.
43. Shida, K., Makino, K., Morishita, A., Takamizawa, K., Hachimura, S., Ametani, A., Sato, T., Kumagai, Y., Habu, S., and Kaminogawa, S., Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocytes cultures, Int. Arch. Allergy Immunol., 115, 278–287, 1998.
44. Matsuzaki, T., Yamazaki, R., Hashimoto, S., and Yokokura, T., Effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice, J. Dairy Sci., 81, 48–53, 1988.
45. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Kato, I., Hashimoto, S., and Yokokura, T., Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei, APMIS, 105, 643–649, 1997.
46. Mike, A., Nagaoka, N., Tagami, Y., Miyashita, M., Shimada, S., Uchida, K., Nanno, M., and Ohwaki, M., Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice, Clin. Exp. Immunol., 117, 368–375, 1999.
47. Kato, I., Endo-Tanaka, K., and Yokokura, T., Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice, Life Sci., 63, 635–644, 1998.
48. Aritaki, S. and Ishikawa, S., Application of milk fermented by L. acidophilus in the pediatric field, J. Jpn. Pediatr. Soc., 66, 125–130, 1962.
49. Yamagishi, T., Serikawa, T., Morita, R., Takahashi, K., and Nishida, S., Effect of a Lactobacillus product administration on the anaerobic intestinal flora of aged adults, Jpn. J. Microbiol., 18, 211–216, 1974.
50. Shirota, M., Aso, K., and Iwabuchi, A., Studies on microflora of the human intestine. I. Alteration of the constitution of intestinal flora by oral administration of L. casei strain Shirota to healthy infants, Jpn. J. Bacteriol., 21, 274–283, 1966.
51. Hanada, K., Kondo, F., Kitahara, R., Tokushige, H., Ueno, T., Kutani, T., and Ochiai, K., Effect of daily administration of Lactobacillus fermented milk on children, J. Kobe Inst. Health, 55–60, 1956.
52. Tanaka, R., Tohyama, K., Morotomi, M., Takayama, H., Nanno, M., Kuroshima, T., and Mutai, M., Effect on the fecal flora and urinary metabolites of the administration of Lactobacillus casei and Bifidobacterium breve, in Proceeding of IRIKEN Symposium on Intestinal Flora: Intestinal Flora and Cancer, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1981, pp. 79–103.
53. Tanaka, R. and Ohwaki, M., A controlled study of the effects of the ingestion of Lactobacillus casei–fermented milk on the intestinal microflora, its microbial metabolism and the immune system of healthy humans, in Proceeding of XII RIKEN Symposium on Intestinal Flora: Intestinal Flora and Diet, Mitsuoka, T., Ed., Japan Scientific Societies Press, Tokyo, 1993, pp. 85–104.
54. Spanhaak, S., Havenaar, R., and Schaafsma, G., The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans, Eur. J. Clin. Nutr., 52, 899–907, 1998.
55. Winkelstein, A., Lactobacillus acidophilus tablets in the therapy of various intestinal disorders: a preliminary report, Am. Proct. Dig. Treat., 1, 1637–1639, 1955.
56. Kawamura, T., Ohnuki, K., and Ichida, F., Clinical study of BLG-01 containing Lactobacillus casei; Effect on irregular bowel movements and abdominal discomfort, Jpn. Pharmacol. Ther., 9, 4361–4370, 1981.
57. Tohyama, K., Kobayashi, S., Kan, T., Yazawa, K., Terashima, T., and Mutai, M., Effect of lactobacilli on urinary indican excretion in gnotobiotic rats and in man, Microbiol. Immunol., 25, 101–112, 1981.
58. Okawa, T., Kita, M., Arai, T., Iida, K., Dokiya, T., Takegawa, Y., Hirokawa, Y., Yamazaki, K., and Hashimoto, S., Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect on tumor reduction and histology, Cancer, 64, 1769–1776, 1989.
59. Masuno, T., Kishimoto, S., Ogura, T., Honma, T., Niitani, H., Fukuoka, M., and Ogawa, A., Comparative trial of LC 9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer, Cancer, 68, 1495–1500, 1991.
60. Okawa, T., Niibe, H., Arai, T., Sekiba, K., Noda, K., Takeuchi, S., Hashimoto, S., and Ogawa, N., Effect of LC 9018 combined with radiation therapy on carcinoma of the uterine cervix, Cancer, 72, 1949–1954, 1993.
61. Aso, Y., Akaza, H., and the BLP Study Group, Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer, Urol. Int., 49, 125–129, 1992.
62. Aso, Y., Akaza, H., Tsukamoto, T., Imai, K., Naito, S., and the BLP Study Group, Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial, Eur. Urol., 27, 104–109, 1995.
63. Sawamura, A., Yamaguchi, Y., Tohge, T., Nagata, N., Ikeda, H., Nakanishi, K., and Asakura, S., Enhancement of immuno-activities by oral administration of Lactobacillus casei in colorectal cancer patients, Biotherapy, 8, 1567–1572, 1994.
64. Nagao, F., Nakayama, M., Muto, T., and Okumura, K., Effects of fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects, Biosci. Biotechnol. Biochem., 64, 2706–2708, 2000.
65. Imai, K., Matsuyama, S., Miyake, S., Suga, K., and Nakachi, K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population, Lancet, 356, 1795–1799, 2000.